Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03617939 · ClinicalTrials.gov registry record
A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
A clinical trial of Cancer Risk, sponsored by University of Colorado, Denver.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 6
- Study locations
NCT03617939: Recruiting study of Cancer Risk, sponsored by University of Colorado, Denver.
NCT03617939 is a study of Cancer Risk that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 20,000 participants, above the 11,171-participant average among 7 other Cancer Risk trials with a reported enrollment target (79% higher). The trial reports 6 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03617939, a study of Cancer Risk, is actively recruiting participants, sponsored by University of Colorado, Denver.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 6
- Study locations
Study Summary
This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.
Primary Outcome
Establish a longitudinal clinical and related data and tissue repository that will contain patient demographics via surveys and questionnaires.
Conditions Studied
Interventions
- OTHER Survey Assessments
- PROCEDURE Biospeciman Collection
- OTHER Medical Chart Reviews
Study Locations (6)
Colorado
- University of Colorado Hospital - Aurora
- UCHealth Memorial Hospital Central - Colorado Springs
- UCHealth Memorial Hospital North - Colorado Springs
- Cherry Creek Medical Center - Denver
- UCHealth Poudre Valley Health System - Fort Collins
- Highlands Ranch Medical Center - Highlands Ranch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2015-09-16 |
| Est. Completion | 2037-09 |
What NCT03617939 shows while recruiting
NCT03617939 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 11,171-participant average among 7 other Cancer Risk trials with a reported enrollment target (79% higher).
The record links to 1 condition, with Cancer Risk appearing as the primary indexed condition, and to 3 interventions - of which Survey Assessments is the first listed.
NCT03617939 lists 6 locations in 1 state (Colorado).
Frequently Asked Questions
What is clinical trial NCT03617939 about?
NCT03617939 is a clinical study titled "A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer". This is not a treatment study. The overall objective is to develop an improved standard of care through studying blood, tissue, biological, etc. samples, that patients have allowed researchers to procure.
What is the current status of trial NCT03617939?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2015-09-16. Estimated completion is 2037-09.
What conditions does trial NCT03617939 study?
This clinical trial studies the following conditions: Cancer Risk.
What interventions are being tested in trial NCT03617939?
The interventions under investigation include: Survey Assessments (OTHER), Biospeciman Collection (PROCEDURE), Medical Chart Reviews (OTHER).
Who is sponsoring clinical trial NCT03617939?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03617939 being conducted?
This trial has 6 study locations across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer Risk
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
RECRUITING · NA
-
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RECRUITING
-
Norris ORIEN Total Cancer Care
RECRUITING
-
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
RECRUITING
-
Morehouse Total Cancer Care Protocol
RECRUITING
-
CanScan; Community-based Registry to Assess, Address and advaNce SCreening for cANcer Prevention and Management
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI